ONWARD Reports Q1 Business Update and Year-To-Date Highlights
16 mai 2023 01h30 HE
|
ONWARD Medical
First-in-Human Use of the ARC-IM™ LeadNew Breakthrough Device Designation Awarded by the U.S. FDA for ARC Therapy™, Bringing Total to 9 10 Additional Patents Issued, Bringing Total Pending and Issued...
ONWARD rapporteert Q1 Business Update en hoogtepunten van het jaar
16 mai 2023 01h30 HE
|
ONWARD Medical
ARC-IM™ afleiding voor het eerst geïmplanteerd bij een mensNieuwe 'Breakthrough Device Designation' toegekend door de Amerikaanse FDA voor ARC Therapy™, waarmee het totaal op 9 komt10 bijkomende...
ONWARD présente une mise à jour de son activité au premier trimestre ainsi que les faits marquants depuis le début de l’exercice
16 mai 2023 01h30 HE
|
ONWARD Medical
L’ARC-IM™ Lead implanté pour la première fois chez un humainNouvelle désignation de dispositif révolutionnaire décernée par la FDA américaine pour ARC Therapy™, portant le total à 910 brevets...
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
15 mai 2023 16h45 HE
|
SeaStar Medical Holding Corporation
DENVER, May 15, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
11 mai 2023 08h00 HE
|
Imunon, Inc.
Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT...
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
11 mai 2023 06h50 HE
|
Synlogic, Inc.
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – - Recent milestones include receipt of Rare Pediatric and Orphan Drug Designations from the FDA, and...
IMUNON to Hold First Quarter 2023 Financial Results and Business Update Conference Call on Thursday, May 11, 2023
04 mai 2023 08h30 HE
|
Imunon, Inc.
LAWRENCEVILLE, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23)
04 mai 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financial & Business update Q3 (January ‘23 - March ‘23) and first 9 months of F.Y. 2022-23 (July ‘22 - March ‘23) Key Facts: 60% revenue growth for the...
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23)
04 mai 2023 02h00 HE
|
GeoJunxion N.V.
GeoJunxion NV (ticker: GOJXN.AS) Financiële en Operationele update 3de kwartaal (januari '23 - maart '23) en eerste 9 maanden van boekjaar 2022-23 (juli '22 - maart '23) Belangrijkste punten: ...
Nexstim Plc Business and Clinical Update Q1 2023
03 mai 2023 02h00 HE
|
Nexstim Oyj
Press release, Helsinki, 3 May 2023 at 9 AM (EEST) Nexstim Plc Business and Clinical Update Q1 2023 Nexstim Plc (NXTMH:HEX) (”Nexstim” or ”Company”) announces the key highlights of the Company’s...